ArticleJournal of clinical microbiology2013
Evaluation of the chromogenic agar chromID C. difficile.
Article in Journal of clinical microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Comparative evaluation of the STANDARD M10 and XpertJournal of clinical microbiology · 2024Article
- Esculin hydrolysis negative and TcdA-only producing strains of Clostridium (Clostridioides) difficile from the environment in Western Australia.Journal of applied microbiology · 2022Article
- Efficacy of Dry Heat Treatment againstPathogens (Basel, Switzerland) · 2022Article
- Comparative Evaluation of Three Immunoassays for the Simultaneous Detection ofMicroorganisms · 2022Article
- Comparison of commercial assays and two-step approach to detectAfrican journal of laboratory medicine · 2022Article
- High levels of toxigenicAccess microbiology · 2020Article
- Molecular Characterization and Moxifloxacin Susceptibility of Clostridium difficile.Antibiotics (Basel, Switzerland) · 2019Article
- Integrated genomic epidemiology and phenotypic profiling of Clostridium difficile across intra-hospital and community populations in Colombia.Scientific reports · 2019Article
- New Insights intoFrontiers in microbiology · 2018Article
- Persistence of Bowl Water Contamination during Sequential Flushes of Contaminated Toilets.Journal of environmental health · 2017Article
- A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.Clinical microbiology reviews · 2017Review
- Role of Single Procalcitonin Test on Admission as a Biomarker for Predicting the Severity ofFrontiers in microbiology · 2017Article
- Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.BMC infectious diseases · 2016Article
- Clostridium difficile Ribotype 023 Lacks the Ability To Hydrolyze Esculin, Leading to False-Negative Results on Chromogenic Agar.Journal of clinical microbiology · 2016Article
- Clostridium difficile infections among adults and children in Mwanza/Tanzania: is it an underappreciated pathogen among immunocompromised patients in sub-Saharan Africa?New microbes and new infections · 2015Article
- Isolation and Identification of Clostridium difficile Using ChromID C. difficile Medium Combined With Gram Staining and PRO Disc Testing: A Proposal for a Simple Culture Process.Annals of laboratory medicine · 2015Article
- Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity of PCR ribotypes.Applied and environmental microbiology · 2015Article
- Laboratory detection of Clostridium difficile in piglets in Australia.Journal of clinical microbiology · 2014Article
- Performance of chromID Clostridium difficile agar compared with BBL C. difficile selective agar for detection of C. difficile in stool specimens.Annals of laboratory medicine · 2014Article
- Evaluation of a chromogenic culture medium for the detection of Clostridium difficile.Yonsei medical journal · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three selective media (chromID C. difficile agar, taurocholate cycloserine cefoxitin agar [TCCA; homemade], and CLO medium) were compared from 406 stool samples of patients suspected of having Clostridium difficile infection. The sensitivities of chromID C. difficile agar at 24 h and 48 h, CLO medium, and TCCA were 74.1%, 87%, 85.2%, and 70.4%, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.